Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure-Reference-Cited by-同舟云学术

Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure

Published:2023-12 Issue:6 Volume:82 Page:481-489
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Nogi Kazutaka,Yamamoto Ryohei,Ueda Tomoya,Nogi Maki,Ishihara Satomi,Nakada Yasuki,Hashimoto Yukihiro,Nakagawa Hitoshi,Nishida Taku,Seno Ayako,Onoue Kenji,Watanabe Makoto,Takaya Norihide,Masuda Izuru,Saito Yoshihiko

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Heidenreich;J Am Coll Cardiol,2022

2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

3. JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure- digest version;Tsutsui;Circ J,2019

4. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group;Collins;Circulation,2015

5. Association of N-terminal pro B-type natriuretic peptide with blood pressure and pulse pressure in elderly people- a cross-sectional population study;Sasaki;Circ J,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Aspects of Using the Results of NT-Probnp Concentration Immunochemical Determination in the Management of Patients With Heart Failure: Support For Clinical Decision-Making;Kardiologiia;2024-08-31

2. Role of B-Type Natriuretic Peptide in the Early Detection of Preclinical Heart Failure　― Is B-Type Natriuretic Peptide the Best Tool to Find the “Invisible Enemy”? ―;Circulation Journal;2024-04-25